The IGF-I generation test revisited: a marker of GH sensitivity - PubMed (original) (raw)
Clinical Trial
. 2001 Nov;86(11):5176-83.
doi: 10.1210/jcem.86.11.8019.
Affiliations
- PMID: 11701674
- DOI: 10.1210/jcem.86.11.8019
Clinical Trial
The IGF-I generation test revisited: a marker of GH sensitivity
C K Buckway et al. J Clin Endocrinol Metab. 2001 Nov.
Abstract
IGF-I generation tests were developed over 20 yr ago and are currently used in differentiating GH insensitivity (GHI) from other disorders characterized by low serum IGF-I. Nevertheless, generation tests have never been adequately characterized, and insufficient normative data are available. One hundred and ninety-eight subjects [including normal subjects; subjects with GHI, GH deficiency (GHD), and idiopathic short stature (ISS); and heterozygotes for the E180 splice GH receptor mutation] were randomized to self-administration of either a high (0.05 mg/kg x d) or a low (0.025 mg/kg x d) dose of GH for 7 d. After a 2-wk washout period, they received the alternate dose. Samples were collected on d 1, 5, and 8 of each treatment period. In normal individuals, IGF-I generation was GH dependent at all ages, and little advantage was observed in using the higher dose of GH or extending beyond the d 5 sample. Some GHD patients had IGF-I levels, both baseline and stimulated, that overlapped levels in the verified GHI patients. Subjects heterozygous for the E180 GH receptor splice mutation did not show a decreased responsiveness to GH. ISS patients had low-normal IGF-I levels that did not stimulate beyond the baseline normative ranges for age. These data provide the first large scale effort to provide preliminary normative IGF generation data and evaluate the GH sensitivity of patients with GHI, GHD, and ISS.
Similar articles
- Insulin-like growth factor binding protein-3 generation as a measure of GH sensitivity.
Buckway CK, Selva KA, Pratt KL, Tjoeng E, Guevara-Aguirre J, Rosenfeld RG. Buckway CK, et al. J Clin Endocrinol Metab. 2002 Oct;87(10):4754-65. doi: 10.1210/jc.2002-020045. J Clin Endocrinol Metab. 2002. PMID: 12364470 Clinical Trial. - Insulin-like growth factor (IGF) parameters and tools for efficacy: the IGF-I generation test in children.
Rosenfeld RG, Buckway C, Selva K, Pratt KL, Guevara-Aguirre J. Rosenfeld RG, et al. Horm Res. 2004;62 Suppl 1:37-43. doi: 10.1159/000080757. Horm Res. 2004. PMID: 15761231 Review. - Leptin concentrations in GH deficiency: the effect of GH insensitivity.
Marzullo P, Buckway C, Pratt KL, Colao A, Guevara-Aguirre J, Rosenfeld RG. Marzullo P, et al. J Clin Endocrinol Metab. 2002 Feb;87(2):540-5. doi: 10.1210/jcem.87.2.8229. J Clin Endocrinol Metab. 2002. PMID: 11836282 - Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
Cohen P, Germak J, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG; American Norditropin Study Group. Cohen P, et al. J Clin Endocrinol Metab. 2010 May;95(5):2089-98. doi: 10.1210/jc.2009-2139. Epub 2010 Mar 5. J Clin Endocrinol Metab. 2010. PMID: 20207829 Clinical Trial. - Short stature related to Growth Hormone Insensitivity (GHI) in childhood.
Mastromauro C, Giannini C, Chiarelli F. Mastromauro C, et al. Front Endocrinol (Lausanne). 2023 Mar 15;14:1141039. doi: 10.3389/fendo.2023.1141039. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37008935 Free PMC article. Review.
Cited by
- Characteristics of intestinal microbiota in children with idiopathic short stature: a cross-sectional study.
Miao J, Lai P, Wang K, Fang G, Li X, Zhang L, Jiang M, Bao Y. Miao J, et al. Eur J Pediatr. 2023 Oct;182(10):4537-4546. doi: 10.1007/s00431-023-05132-8. Epub 2023 Jul 31. Eur J Pediatr. 2023. PMID: 37522979 - Balanced assessment of growth disorders using clinical, endocrinological, and genetic approaches.
Savage MO, Storr HL. Savage MO, et al. Ann Pediatr Endocrinol Metab. 2021 Dec;26(4):218-226. doi: 10.6065/apem.2142208.104. Epub 2021 Dec 31. Ann Pediatr Endocrinol Metab. 2021. PMID: 34991299 Free PMC article. - GH Resistance Is a Component of Idiopathic Short Stature: Implications for rhGH Therapy.
Savage MO, Storr HL. Savage MO, et al. Front Endocrinol (Lausanne). 2021 Dec 10;12:781044. doi: 10.3389/fendo.2021.781044. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34956092 Free PMC article. Review. - Investigating whether serum IGF-1 and IGFBP-3 levels reflect the height outcome in prepubertal children upon rhGH therapy: LG growth study database.
Kim M, Kim EY, Kim EY, So CH, Kim CJ. Kim M, et al. PLoS One. 2021 Nov 1;16(11):e0259287. doi: 10.1371/journal.pone.0259287. eCollection 2021. PLoS One. 2021. PMID: 34723984 Free PMC article. - Growth failure: 'idiopathic' only after a detailed diagnostic evaluation.
Rapaport R, Wit JM, Savage MO. Rapaport R, et al. Endocr Connect. 2021 Mar;10(3):R125-R138. doi: 10.1530/EC-20-0585. Endocr Connect. 2021. PMID: 33543731 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources